Medclair AB (NGM:MCLR) Accumulated Depreciation: kr0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:MCLR Medclair AB NGM:MCLR
68 GF Score
Price kr3.10
GF Value kr2.21
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Medclair AB Accumulated Depreciation?

Medclair AB NGM:MCLR +7.27% 68 Accumulated Depreciation is kr0.00 Mil as of Jun. 2026. GuruFocus rates NGM:MCLR with a GF Score™ of 68/100 and a GF Value™ of kr2.21 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Medclair AB's quarterly accumulated depreciation declined from Dec. 2025 (kr-2.46 Mil) to Mar. 2026 (kr0.00 Mil) but then stayed the same from Mar. 2026 (kr0.00 Mil) to Jun. 2026 (kr0.00 Mil).

Medclair AB's annual accumulated depreciation increased from Dec. 2023 (kr-1.40 Mil) to Dec. 2024 (kr-1.55 Mil) and increased from Dec. 2024 (kr-1.55 Mil) to Dec. 2025 (kr-2.46 Mil).

Medclair AB Accumulated Depreciation Related Terms

Medclair AB Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Medclair AB's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medclair AB Accumulated Depreciation Chart

Medclair AB Annual Data
Trend Apr16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.72 -0.90 -1.40 -1.55 -2.46

Medclair AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -2.46 0.00 0.00
NGM:MCLR
68GF Score
Medclair AB NGM:MCLR
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medclair AB Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of kr0.00 Mil mean?
Medclair AB (NGM:MCLR) has a Accumulated Depreciation of kr0.00 Mil as of Jun. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Medclair AB and its competitors.
Is Medclair AB's Accumulated Depreciation too high?
Medclair AB's current Accumulated Depreciation is kr0.00 Mil. Overall, Medclair AB has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medclair AB's Accumulated Depreciation compare to ABT and SYK?
Medclair AB's Accumulated Depreciation of kr0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Medical Devices & Instruments company?
A good Accumulated Depreciation depends on the Medical Devices & Instruments industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Medclair AB and its competitors. Medclair AB's current Accumulated Depreciation is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medclair AB stock overvalued right now?
Based on GuruFocus' analysis, Medclair AB (NGM:MCLR) is currently considered Significantly Overvalued. The stock's GF Value™ is kr2.21, compared to a current price of kr3.10 — trading 40.3% above its estimated fair value. The current Accumulated Depreciation is kr0.00 Mil. Medclair AB's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Medclair AB (NGM:MCLR), the current Accumulated Depreciation is kr0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medclair AB (NGM:MCLR) Overvalued in 2026?

Based on GuruFocus' analysis, Medclair AB stock appears to be overvalued. The current stock price of kr3.10 is trading 40.3% above its estimated GF Value™ of kr2.21. GuruFocus considers Medclair AB to be Significantly Overvalued.

Key valuation signals for NGM:MCLR:

  • Accumulated Depreciation: kr0.00 Mil
  • GF Value™: kr2.21 vs. price of kr3.10 (40.3% above fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the NGM:MCLR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medclair AB Business Description

Address Fraktflygargatan 1, Stockholm, SWE, 128 30
Medclair AB operates in healthcare industry. The company has two units: Central Destruction Unit (CDU) and Mobile Destruction Unit (MDU) decomposes the nitrous oxide entering the unit, transforming it to nitrogen (N2) och oxygen (O2). It also provide solutions for various N2O methods such as double mask, single mask, mouthpiece, or free flow, which ensures a safe work environment for healthcare professionals.
68GF Score

Get the complete analysis for NGM:MCLR

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.10
Price
kr2.21
GF Value